WuXi Biologics Released a New cGMP Drug Product Manufacturing Facility to Support End-to-End Services for Diversified Modalities ...Middle East

WuXi Biologics adds further capacity and capability for drug product fill & finish, providing global customers with end-to-end integrated solutions for diversified modalities, including mRNA-LNP HANGZHOU, China, Oct. 23, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a...

Hence then, the article about wuxi biologics released a new cgmp drug product manufacturing facility to support end to end services for diversified modalities was published today ( Monday 24/10/2022 - 03:40 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( WuXi Biologics Released a New cGMP Drug Product Manufacturing Facility to Support End-to-End Services for Diversified Modalities )

Also on site :

• France to ditch American video conferencing services
• EU’s Kallas privately complaining about ‘dictator’ von der Leyen – Politico
• Bob Iger Just Walked the Site of Disney’s Next Theme Park